Paul N. Cheng

1.3k total citations
25 papers, 688 citations indexed

About

Paul N. Cheng is a scholar working on Biotechnology, Molecular Biology and Oncology. According to data from OpenAlex, Paul N. Cheng has authored 25 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Biotechnology, 8 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Paul N. Cheng's work include Cancer Research and Treatments (14 papers), Virus-based gene therapy research (8 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Paul N. Cheng is often cited by papers focused on Cancer Research and Treatments (14 papers), Virus-based gene therapy research (8 papers) and Cancer, Hypoxia, and Metabolism (7 papers). Paul N. Cheng collaborates with scholars based in Hong Kong, China and United States. Paul N. Cheng's co-authors include Wai‐Hung Lo, Yun‐Chung Leung, Alan Tin‐Lun Lam, Hiu‐Chi Chong, Denys N. Wheatley, Shi Xu, Jcm Ho, Sze Kwan Lam, John K. C. Chan and Thomas Yau and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Scientific Reports.

In The Last Decade

Paul N. Cheng

25 papers receiving 675 citations

Peers

Countries citing papers authored by Paul N. Cheng

Since Specialization

Citations

This map shows the geographic impact of Paul N. Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul N. Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul N. Cheng more than expected).

Fields of papers citing papers by Paul N. Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul N. Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul N. Cheng. The network helps show where Paul N. Cheng may publish in the future.

Co-authorship network of co-authors of Paul N. Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Paul N. Cheng. A scholar is included among the top collaborators of Paul N. Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul N. Cheng. Paul N. Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PEG-BCT-100 and Canavanine Synergistically Induce Apoptosis in Arginine Biosynthetic Enzyme-Deficient Pancreatic Cancer 2024 ·Cancer Research Communications ·(unknown), (unknown), Chi Hang Wong, Anthony W.H. Chan, Landon L. Chan, Ksh Chok, Paul N. Cheng, Stephen L. Chan	1
2	Targeting proliferative retinopathy: Arginase 1 limits vitreoretinal neovascularization and promotes angiogenic repair 2022 ·Cell Death and Disease ·Abdelrahman Y. Fouda, Zhimin Xu, Jutamas Suwanpradid, Modesto Rojas, Esraa Shosha, Tahira Lemtalsi, Chintan Patel, Xing Ji, Syed Zaidi, Wenbo Zhi, (unknown), Paul N. Cheng, S. Priya Narayanan, Robert W. Caldwell, Ruth B. Caldwell	17
3	Preclinical investigation of Pegylated arginase 1 as a treatment for retina and brain injury 2021 ·Experimental Neurology ·Abdelrahman Y. Fouda, Wael Eldahshan, Zhimin Xu, Tahira Lemtalsi, Esraa Shosha, Syed Zaidi, (unknown), Paul N. Cheng, S. Priya Narayanan, Robert W. Caldwell, Ruth B. Caldwell	12
4	Pegylated Recombinant Human Arginase 1 Induces Autophagy and Apoptosis via the ROS‐Activated AKT/mTOR Pathway in Bladder Cancer Cells 2021 ·Oxidative Medicine and Cellular Longevity ·(unknown), (unknown), (unknown), (unknown), Changneng Ke, (unknown), Jcm Ho, Paul N. Cheng, Shi Xu	15
5	A phase 1 study of pegylated recombinant arginase (PEG-BCT-100) in combination with systemic chemotherapy (capecitabine and oxaliplatin)[PACOX] in advanced hepatocellular carcinoma patients 2021 ·Investigational New Drugs ·Thomas Yau, Paul N. Cheng, Joanne Chiu, Gerry Gin Wai Kwok, Roland Leung, Angela M. Liu, Tan To Cheung, (unknown)	17
6	A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinoma 2021 ·Investigational New Drugs ·Stephen L. Chan, Paul N. Cheng, Angela M. Liu, Landon L. Chan, Leung Li, Cheuk Man Chu, Charing C. N. Chong, (unknown), Winnie Yeo, Kelvin K. Ng, Simon C.H. Yu, Tony Mok, Anthony W.H. Chan	31
7	Endogenous arginase 2 as a potential biomarker for PEGylated arginase 1 treatment in xenograft models of squamous cell lung carcinoma 2019 ·Oncogenesis ·Sze Kwan Lam, Sheng Yan, Shi Xu, (unknown), Paul N. Cheng, Jcm Ho	7
8	Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes 2018 ·Scientific Reports ·Constantia Alexandrou, (unknown), Jennifer A. Higgins, William Boyle, Ankur Karmokar, Catherine Andreadi, Jinli Luo, David A. Moore, Maria Viskaduraki, Matthew Blades, Graeme I. Murray, Lynne Howells, Anne Thomas, Karen Brown, Paul N. Cheng, Alessandro Rufini	67
9	Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts 2017 ·Respiratory Research ·Sze Kwan Lam, Yuanyuan Li, Shi Xu, Leanne Lee Leung, (unknown), Yanfang Zheng, Paul N. Cheng, Jcm Ho	23
10	Deprivation of arginine by recombinant human arginase in prostate cancer cells 2012 ·Journal of Hematology & Oncology ·Eddy C. Hsueh, (unknown), Wai‐Hung Lo, Yun‐Chung Leung, Paul N. Cheng, Chung-Tsen Hsueh	68
11	A phase 1 dose-escalating study of pegylated recombinant human arginase 1 (Peg-rhArg1) in patients with advanced hepatocellular carcinoma 2012 ·Investigational New Drugs ·Thomas Yau, Paul N. Cheng, Pierre Chan, William Chan, Li Chen, Jimmy Yuen, Roberta Pang, Sheung Tat Fan, Ronnie T.P. Poon	87
12	Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis 2010 ·Pigment Cell & Melanoma Research ·Alan Tin‐Lun Lam, (unknown), (unknown), Hiu‐Chi Chong, (unknown), (unknown), Paul N. Cheng, Denys N. Wheatley, Wai‐Hung Lo, Yun‐Chung Leung	81
13	Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest 2009 ·Cancer Letters ·Alan Tin‐Lun Lam, (unknown), Hiu‐Chi Chong, Paul N. Cheng, (unknown), (unknown), Sui-Yi Kwok, Ronnie T.P. Poon, Denys N. Wheatley, Wai‐Hung Lo, Yun‐Chung Leung	66
14	Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC) 2009 ·Cancer Cell International ·S. M. Tsui, (unknown), Alan Tin‐Lun Lam, Hiu‐Chi Chong, Pui‐Kin So, Sui-Yi Kwok, (unknown), Paul N. Cheng, Denys N. Wheatley, Wai‐Hung Lo, Yun‐Chung Leung	59
15	Failure to confirm major objective antitumor activity for streptozocin and doxorubicin in the treatment of patients with advanced islet cell carcinoma 1999 ·Cancer ·Paul N. Cheng, Leonard B. Saltz	7
16	Immunohistological characteristics of the infiltrating lymphoid cells and expression of HLA class I and II antigens in nasopharyngeal carcinoma 1990 ·Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·(unknown), Paul N. Cheng, S.Y. Tsao, Kar Neng Lai	15
17	A study of lymphocyte kinetics in nasopharyngeal carcinoma with indium III oxine-labelled lymphocytes. 1988 ·PubMed ·Paul N. Cheng, (unknown), (unknown), Stephen Ho, (unknown), C. Metreweli	1
18	Peripheral Blood Lymphocyte Subsets in Nasopharyngeal Carcinoma 1987 ·Oncology ·C.S. Ng, William L. Chick, S.Y. Tsao, (unknown), Joseph J.�Y. Sung, (unknown), W. Shiu, Paul N. Cheng, William McChesney Martin	2
19	Palliative treatment of malignant ascites by intraperitoneal bleomycin after dialytic ultrafiltration with haemofilter 1987 ·Journal of Gastroenterology and Hepatology ·Kar Neng Lai, Joseph W. Leung, Paul N. Cheng, Fernand Mac-Moune Lai	1
20	Nasal T-cell lymphoma associated with hemophagocytic syndrome 1986 ·Cancer ·(unknown), John K. C. Chan, Paul N. Cheng, (unknown)	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact